Cargando…
Resistance to Anti-angiogenic Therapies: A Mechanism Depending on the Time of Exposure to the Drugs
Angiogenesis, the formation of new blood vessels from preexisting one, represents a critical process for oxygen and nutrient supply to proliferating cells, therefore promoting tumor growth and metastasis. The Vascular Endothelial Growth Factor (VEGF) pathway is one of the key mediators of angiogenes...
Autores principales: | Montemagno, Christopher, Pagès, Gilles |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7381352/ https://www.ncbi.nlm.nih.gov/pubmed/32775327 http://dx.doi.org/10.3389/fcell.2020.00584 |
Ejemplares similares
-
Resistance Mechanisms of Anti-angiogenic Therapy and Exosomes-Mediated Revascularization in Cancer
por: Zeng, Ye, et al.
Publicado: (2020) -
Therapy for Cancer: Strategy of Combining Anti-Angiogenic and Target Therapies
por: Comunanza, Valentina, et al.
Publicado: (2017) -
Mechanisms of Pharmaceutical Therapy and Drug Resistance in Esophageal Cancer
por: Mao, Chengyi, et al.
Publicado: (2021) -
Resistance Mechanisms of Anti-PD1/PDL1 Therapy in Solid Tumors
por: Lei, Qingyang, et al.
Publicado: (2020) -
Therapy Induced Genome Chaos: A Novel Mechanism of Rapid Cancer Drug Resistance
por: Ye, Jing Christine, et al.
Publicado: (2021)